Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety in the Combination Usage of Cerdelga and Cerezyme in Type III Gaucher Disease Patients and the Efficacy on Soft Tissue Diseases.

NCT03519646 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03519646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03519646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety in the Combination Usage of Cerdelga and Cerezyme in Type III Gaucher Disease Patients and the Efficacy on Soft Tissue Diseases.
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 23, 2018
Completion date
September 11, 2020
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher disease, type iii